06th week of 2016 patent applcation highlights part 10 |
Patent application number | Title | Published |
20160038608 | SILICA-BASED MESOPOROUS CARRIER AND DELIVERY METHOD OF USING THE SAME - Mesoporous carriers for delivering targets into a cell are provided. The mesoporous carriers comprise hollow silica nanospheres (HSN) or mesoporous silica nanoparticles (MSN) and the targets bound to or encapsulated by the hollow silica nanospheres or the mesoporous silica nanoparticles. The targets includes at least two different targets, and the targets may include peptides, proteins, enzymes and/or enzymatic mimetics. | 2016-02-11 |
20160038609 | Multistage Nanoparticles - Multistage nanostructures, e.g., for delivery of agents such as imaging agents and therapeutic agents to tumor vasculature. | 2016-02-11 |
20160038610 | COMPOSITIONS AND METHODS FOR IMAGING AND TREATMENT - Provided are compositions and methods for transport, monitoring the transport, and controlled release of active agents. The compositions comprise surface functionalized iron oxide nanoparticles. The iron oxide nanoparticles are surface functionalized with cucurbitril[7] macrocycles. The cavity formed by the CB[7] macrocycles can be used for storage and transport of active agents. The active agents may be imaging agents or may be therapeutic agents which can be released by applying an alternating magnetic field at desired locations. | 2016-02-11 |
20160038611 | Nanofibre and Bioactive Compositions and Related Methods - Described herein are compositions in nanofibre form including one or more bioactive compounds releasably incorporated thereon. In one embodiment a composition is described comprising at least one nanofibre and at least one bioactive compound. The nanofibres are formed from a base material that is solubilised with the bioactive or bioactives in an aqueous based solvent solution and the base material and bioactives are together spun via electrospinning to form dry fibres with the bioactives chemically bonded to the nanofibres and the bioactives remaining stable during storage of the composition under ambient conditions substantially free of moisture. On exposure to moisture, the nanofibres dissolve, thereby releasing the bioactives. | 2016-02-11 |
20160038612 | FORMULATION AND DELIVERY OF MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS - The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity. | 2016-02-11 |
20160038613 | DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9 - The present invention relates to Adeno-associated virus 9 methods and materials useful for systemically delivering polynucleotides across the blood brain barrier. Accordingly, the present invention also relates to methods and materials useful for systemically delivering polynucleotides to the central and peripheral nervous systems. The present invention also relates to Adeno-associated virus type 9 methods and materials useful for intrathecal delivery of polynucleotides. Use of the methods and materials is indicated, for example, for treatment of lower motor neuron diseases such as spinal muscle atrophy and amyotrophic lateral sclerosis as well as Pompe disease and lysosomal storage disorders. Use of the methods and materials is also indicated, for example, for treatment of Rett syndrome. | 2016-02-11 |
20160038614 | ORAL ANESTHESIA APPLICATION - The present invention provides a device for administering an active agent to a localized mucous membrane in the oral cavity of a mammal, as well as an oral dissolving film formed therefore. | 2016-02-11 |
20160038615 | SACCHARIDE CONJUGATES - This invention relates to compounds comprising a saccharide conjugated to an imaging agent or a reporter group, compositions comprising them and methods of using them. Specifically BLM-disaccharide and BLM-monosaccharide conjugates containing different linker groups and an imaging agent or a reporter group are provided for the targeting and imaging of tumors. | 2016-02-11 |
20160038616 | METHOD OF MONITORING THE RELEASE FROM LIPOSOMES OF A PRODUCT OF INTEREST USING SUPERPARAMAGNETIC NANOPARTICLES - The present application relates to a method of monitoring the membrane permeabilization of liposome and the incidental release of a compound of interest. | 2016-02-11 |
20160038617 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS - The present application discloses treating water insoluble nanoparticles, particularly nanoparticles of metals and metal compounds which find utility in diagnostic imaging such as MR and X-ray imaging, with an alpha-hydroxyphosphonic acid conjugate with a hydrophilic moiety to render the nanoparticles sufficiently hydrophilic to find utility in diagnostic imaging. Among the modified hydrophilic nanoparticles disclosed are those in which the hydrophilic moieties of the modifying conjugate are ethylene oxide based polymers and copolymers and zwitterions and the nanoparticles are composed of transition metal oxides such as superparamagnetic iron oxide and tantalum oxide. Disclosed are nanoparticles which are sufficiently hydrophilic to form stable aqueous colloidal suspensions. Also disclosed is diagnostic imaging such as MR and X-ray using the modified hydrophilic nanoparticles as contrast agents. | 2016-02-11 |
20160038618 | PLASMONIC SUB-100 NM NANOMATRYOSHKAS THAT CONFINE CONTRAST AGENTS WITHIN LAYERS OF METAL - A magnetic resonance imaging enhancement agent includes a plurality of particles. Each particle including a metal core; a dielectric shell disposed on the metal core including water and at least one MRI contrast agent; and a metal shell disposed on the exterior surface of the dielectric shell that encapsulates the dielectric shell. | 2016-02-11 |
20160038619 | SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS - Fluoridated organofluoroborates comprising at least one | 2016-02-11 |
20160038620 | AROMATIC AMINO ACID DERIVATIVE AND POSITRON EMISSION TOPOGRAPHY (PET) PROBE USING THE SAME - A compound having a structure represented by the general formula (I): | 2016-02-11 |
20160038621 | OPTICAL FIBER BASED ANTIMICROBIAL ULTRAVIOLET RADIATION THERAPY SYSTEM - An ultraviolet irradiation system includes a medical device having a central lumen, an optical fiber having a longitudinal length, and an ultraviolet wave generator, wherein ultraviolet waves generated by the wave generator are dispersed along the longitudinal length of the optical fiber to disinfect the central lumen of the medical device. | 2016-02-11 |
20160038622 | FOOTWEAR SANITIZING AND DEODORIZING SYSTEM - Introducing ultraviolet (UV) light to activate a light sensitive chemical compound applied to interior portions of footwear alters the environment inside a shoe or other footwear to destroy microorganisms or inhibit their growth. Visible light can also be used to prevent further microorganism growth. Introducing forced air flow through the footwear removes dampness in and thereby deodorizes the footwear. A preferred embodiment comprises an adjustable shoe tree equipped with a UV germicidal light source and electronic safeguards that prevent appreciable leakage of UV radiation outside the shoe. | 2016-02-11 |
20160038623 | FRAGRANCE ENHANCER - The present invention relates to fragrance enhancers for use in conjunction with candles to enhance the dispersion of the fragrance therefrom and/or increase the combustion efficiency thereof. In one embodiment, the fragrance enhancer of the present invention comprises a body that is mounted to an upper surface of the holder and further comprises a mounting bracket for holding a fan assembly that is mounted to the holder. In one instance, the fan assembly includes a plurality of inverted blades, and a gap is formed between the body and the holder to enable air flow through the body. In another embodiment the fragrance enhancer of the present invention comprises a cylindrically-shaped perforated body, the cylindrically-shaped perforated body having openings located at both the top and bottom thereof. In this embodiment the fragrance enhancer of the present invention further comprises a fan assembly formed from inclined blades. | 2016-02-11 |
20160038624 | UV STERILIZATION APPARATUS, SYSTEM, AND METHOD FOR FORCED-AIR PATIENT HEATING SYSTEMS - An improvement to UV sterilization and disinfection devices and methods is disclosed. An apparatus for sterilization and disinfection includes: a compact, highly effective air sterilization and disinfection apparatus, which delivers clean, pure air directly into a blower/warmer device for clean and effective management of patient body temperature. | 2016-02-11 |
20160038625 | Photo-Catalyzing Fluid Mobilizing System And Method - A photo-catalyzing fluid mobilizing system and method are disclosed. A chamber has a power source. A fluid mobilizer is mounted in the chamber and connected with the power source to mobilize a fluid through the chamber. The fluid mobilizer includes one or more fan blades that are coated with a photo catalyst. A UV light source is mounted in the chamber proximate the fluid mobilizer and connected with the power source to catalyze the photo catalyst coating the blades to purifier the fluid being mobilized thereover. | 2016-02-11 |
20160038626 | PROTEASE MODULATING WOUND INTERFACE LAYER FOR USE WITH NEGATIVE PRESSURE WOUND THERAPY - Systems, methods, and apparatuses for modulating proteases including matrix metalloproteinase (MMP), elastase, and bacterial protease in a negative pressure therapy system are described. A mesh having a sacrificial substrate is included. The sacrificial substrate includes a plurality of collagen fibers reinforced with a supporting material and intersecting with each other to form a network of collagen fibers having a plurality openings. The openings of the plurality of openings have an average area between about 0.5 mm | 2016-02-11 |
20160038627 | METHOD OF CAUSING DELAYED HEMOSTASIS - A method of causing delayed hemostasis. A hemostatic product is formed by applying a hemostatic agent to a dextran support. The hemostatic agent is provided with at least one of a reduced concentration and a reduce availability. The hemostatic product is applied to a wound from which blood is being discharged. At least one foreign object or pathogen is proximate the wound. Hemostasis is progressively caused so that blood continues to be discharged from the wound to cause the at least one foreign object or pathogen to move away from the wound. | 2016-02-11 |
20160038628 | WETNESS INDICATOR WITH PERMANENT COLORANT - A wetness indicating composition is provided, comprising a liquid-activated colorant, a permanent colorant, and a binding matrix. | 2016-02-11 |
20160038629 | Adhesive Properties - Various adhesive compositions are described which may optionally comprise one or more active agents such as pharmaceutical agents. The incorporation of one or more absorbents in combination with one or more crystallization inhibitors improves adhesive characteristics of the compositions. Also described are related methods of improving adhesive characteristics of adhesive compositions with the use of a combination of absorbent and inhibitor. Also described are related methods of using the compositions and articles incorporating such compositions. | 2016-02-11 |
20160038630 | MALLEABLE, BIODEGRADABLE HEMOSTATIC AGENT - A malleable, biodegradable hemostatic agent is provided that can be used for mechanical sealing of bleeding bone tissue, as well as a method for forming a malleable, biodegradable hemostatic agent of this type, and a medical implant having a coating that includes a malleable, biodegradable hemostatic agent of this type. The malleable, biodegradable hemostatic agent contains (a) at least one saturated glycerol-1,2,3-tri-fatty acid ester having a melting temperature above 37° C., (b) at least one filling agent present in particulate form, at least in part, and having a melting temperature above 37° C., and (c) at least one compound having a melting temperature not above 37° C. and a solubility at a temperature of 25° C. of less than 50 grams per liter of water. | 2016-02-11 |
20160038631 | Acrylic Cements for Bone Augmentation - The embodiments relate to an injectable composition for a bone cement material comprising a dry powder component, a liquid component and a modifier configured to modify a Young's modulus of the bone cement material. The modifier is linoleic acid or a derivative thereof and is present in a concentration of 0.1 to 12 v/v of the liquid component. | 2016-02-11 |
20160038632 | Adaptive Drug Delivery from an Artificial Polymer Skin with Tunable Properties for Tissue Engineering - The present invention provides, among other things, a composite device comprised of a porous polymer membrane carrying active growth factors. Composite devices are characterized by an ability to controllably degrade for repair of bone and/or tissue defects sustained from traumatic wounds or congenital defects through eluting growth factor over readily adapted time scales inducing a natural wound healing cascade and rapid bone repair. Methods of making and using provided devices are also disclosed. | 2016-02-11 |
20160038633 | ADDITIVE MANUFACTURING POWDER AND METHOD OF MANUFACTURING THE SAME - Additive manufacturing powder contains a core-shell type particle containing a core particle comprising a first binder resin and a filler and a shell present on the surface of the core particle. The shell contains a second binder resin. The powder has a particle size distribution Dv/Dn of 1.5 or less and an average circularity of from 0.800 to 0.980, the average circularity being represented by the following relation: | 2016-02-11 |
20160038634 | CARBOXYMETHYLCELLULOSE POLYETHYLENE GLYCOL COMPOSITIONS FOR MEDICAL USES - Uses of compositions comprising carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS in the presence of NH | 2016-02-11 |
20160038635 | FILLER COMPOSITION FOR THE TREATMENT OF LIPOATROPHY - The present invention refers to a composition that is useful as a filler for the correction of soft tissue volume loss, for example for the cosmetic treatment of wrinkles, or for the treatment of disorders such as lipoatrophy or lipodystrophy in general, said composition comprising agarose and hyaluronic acid, or a pharmaceutically acceptable salt thereof. The particular interaction that takes place between the two components makes even high concentrations of agarose injectable and tolerable, said high concentrations being particularly useful for ensuring the duration and stability over time of the aesthetic results that are achievable using this filler. | 2016-02-11 |
20160038636 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES - The present invention relates to water soluble quaternized chitosan derivatives which form hydrogel matrix with broad antimicrobial properties for the protection and coating of medical device. Hydrogel is attractive as an antimicrobial coating since its hydrophilicity intrinsically prevents the reversible nonspecific attachment of microbes. In order to achieve hydrogel formation, quaternized chitosan can be grafted with polymerizable groups, especially photocrosslinkable groups, such as methacrylates, PEG derivatives and be converted into hydrogels through a thermal or UV polymerization process. Hydrogels are hydrated cross-linked polymeric systems that contain water in an equilibrium state forming cushion water shield. The present invention is widely used in many medical devices. This invention describes the formation of novel hydrogels based on quaternized ammonium chitosan derivatives which has been grafted with photocrosslinkable groups, hence providing hydrogels as antimicrobial water shield coating agent. | 2016-02-11 |
20160038637 | MODIFIED SILK FILMS CONTAINING GLYCEROL - The present invention provides for compositions and methods for preparing aqueous insoluble, ductile, flexible silk fibroin films. The silk films comprise silk fibroin and about 10% to about 50% (w/w) glycerol, and are prepared by entirely aqueous processes. The ductile silk film may be further treated by extracting the glycerol from and re-drying the silk film. Active agents may be embedded in or deposited on the glycerol modified silk film for a variety of medical applications. The films may be shaped into 3-dimentional structures, or placed on support surfaces as labels or coatings. The glycerol modified silk films of the present invention are useful in variety of applications such as tissue engineering, medical devices or implants, drug delivery, and edible pharmaceutical or food labels. | 2016-02-11 |
20160038638 | PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME - Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane. | 2016-02-11 |
20160038639 | COMPOSITIONS OF AND METHODS FOR CANCELLOUS BONE MATRIX - A bone repair composition including a cancellous bone matrix with cortical and/or cancellous bone particles loaded therein; and a kit comprising the cancellous bone matrix and the cortical and/or cancellous bone particles. | 2016-02-11 |
20160038640 | ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS - The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation. | 2016-02-11 |
20160038641 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR - Compositions of small molecules, matrices, and isolated cells including methods of preparation, and methods for differentiation, transdifferentiation, and proliferation of animal cells into the osteoblast blast cell lineage were described. Examples of osteogenic materials that were administered to cells or co-cultured with cells are represented by compounds of Formula II, IV, and VI independently or preferably in combination with a matrix to afford bone cells. Small molecule-stimulated cells were also combined with a matrix, placed with a cellular adhesive or material carrier and implanted to a site in an animal for bone repair. Matrix pretreated with compounds of Formula II, IV, and VI were also used to cause cells to migrate to the matrix that is of use for therapeutic purposes. | 2016-02-11 |
20160038642 | OSTEOGENIC CELL DELIVERY MATRIX - Compositions and methods for augmenting bone formation by administering isolated human mesenchymal stem cells (hMSCs) within a matrix provided. By adding calcium and/or phosphate ions to the matrix, one may foster greater bone regeneration. | 2016-02-11 |
20160038643 | HYDROGEL PRECURSORS HAVING NANOPARTICLES - An implantable hydrogel precursor composition can include: a cross-linkable polymer matrix that is biocompatible; and a plurality of polymer particles in the cross-linkable polymer matrix. The cross-linkable polymer matrix can include a cross-linkable hyaluronic acid polymer that has cross-linkable functional groups. The hyaluronic acid polymer can be a methacrylated hyaluronic acid polymer. The methacrylated hyaluronic acid polymer can have a molecular weight from about 500 kDa to about 1.8 MDa. The polymer particles can include a cross-linked hyaluronic acid. The cross-linkable polymer matrix having the polymer particles has a yield stress. The cross-linkable polymer matrix having the polymer particles has shape retention at physiological temperatures. The composition can include live cells in the cross-linkable polymer matrix. The composition can include a biologically active agent in the cross-linkable polymer matrix. | 2016-02-11 |
20160038644 | Compositions for Regenerating Defective or Absent Myocardium - Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function. | 2016-02-11 |
20160038645 | POLYMERIC MESH WITH SELECTIVE PERMEABILITY, FOR THE REPAIR AND REGENERATION OF TISSUES - The present application describes a polymeric mesh for the repair and regeneration of tissues from an organism that comprises pores wherein at least 70% of the pores of the said mesh have a size smaller than the one required to confine the cells of the said tissues, and wherein at least 70% of the pores of the said mesh has a size superior than the one needed for the passage of interstitial fluids of the said tissues; the degradation time of the said polymeric mesh within the organism is at least 8 weeks; the said polymeric mesh has an apparent tensile strength superior than 1 MPa; the said polymeric mesh has an apparent elastic modulus superior than 0.1 MPa. The mesh described in this application allows that the “new tissue” formed presents very similar properties to the ones of the damaged tissue. | 2016-02-11 |
20160038646 | COMPOSITIONS AND METHODS FOR ENHANCING HEALING AND REGENERATION OF BONE AND SOFT TISSUE - The invention features biodegradable materials, and in vitro and in vivo methods of using such compositions to promote bone and soft tissue growth and healing. | 2016-02-11 |
20160038647 | THIN-FILM COATED FLUOROPOLYMER CATHETER - A fluoropolymer medical device (e.g., a sphincterotome) has a thin-film coating deposited using a technique such as Atomic Layer Deposition. The thin-film coating may be a ceramic coating or a metal coating and a ceramic coating may further have an overlying ink coating such as a conducting ink or a radiopaque marker. The ceramic coating improves the application and adherence of the ink coating to the fluoropolymer device. | 2016-02-11 |
20160038648 | Encapsulated Drug Compositions and Methods of Use Thereof - Various aspects of the present disclosure provide compositions, coatings and implantable devices including a drug and an excipient. In certain embodiments the excipient and the drug are present at a weight ratio of between 10 to 1 and 1 to 10 drug to excipient. In certain other embodiments, the excipient and the drug form particles in which the drug is encapsulated by the excipient. Other aspects of the disclosure provide methods of manufacturing and using such compositions, coatings and implantable devices. | 2016-02-11 |
20160038649 | Inflatable Imbibed Polymer Devices - The present invention provides a stretchable material suitable for use in an inflatable medical device. The stretchable material has at least one reinforcing polymer layer with a top and bottom side forming a porous matrix which is imbibed with a sealing material to infiltrate and substantially seal spaces of the porous matrix and extend beyond the reinforcing polymer layer to form a surface coating. | 2016-02-11 |
20160038650 | Systems and Methods for Microbial Resistance Zones to Selectively Present Prophylactically and Therapeutically Active Agents - A cystostomy device for implant in a patient includes a transcutaneous sleeve a flange connected to the transcutaneous sleeve, adapted to reduce contamination of an outer surface of said transcutaneous sleeve, a catheter defining a passage for the flow of fluids from within the patient to outside the patient, an inner surface of the transcutaneous sleeve defining a path through which the catheter passes, and an anchor adapted for implantation into the biological tissue of the patient, the anchor connecting to the catheter and the transcutaneous sleeve. At least one microbe resistance zone is included on surfaces in any of the sleeve, the flange, and the catheter. The microbe resistance zone may be formed on the surfaces of the sleeve, flange and catheter, or may be adhered to the device as tape that may be rolled. A micropore filter prevents back flow of urine from a urinary bag. | 2016-02-11 |
20160038651 | COMPOUNDS AND COMPOSITIONS FOR DRUG RELEASE - The invention relates to compounds that include biologically active agents (e.g., compounds according to any of formulas (I) and (I-A) that can be used for effective drug release, e.g., as coatings for medical devices. Use of these compounds in the coating of surfaces can allow for long-term drug release as well as imparting uniform coatings with little phase separation compared to, e.g., the parent biologically active agent. | 2016-02-11 |
20160038652 | METHODS OF APPLYING A HYDROPHILIC COATING TO A SUBSTRATE, AND SUBSTRATES HAVING A HYDROPHILIC COATING - This invention relates to methods of applying to a substrate a hydrophilic coating that becomes lubricious when activated with water or water vapor, and to substrates having such a hydrophilic coating. | 2016-02-11 |
20160038653 | IN-VIVO BIODEGRADABLE MEDICAL IMPLANT COMPRISING A MICROSTRUCTURE ENGINEERED METALLIC MATERIAL - In-vivo biodegradable medical implants, containing at least in part at least partially fine-grained metallic materials provide a strong, tough, stiff and lightweight implant. The in-vivo biodegradable implants are used in a number of stent applications, for fracture fixation, sutures and the like. The in-vivo biodegradable medical implants enable the reduction of implant size and weight and consequently result in reducing the release of implant degradation products into the body. | 2016-02-11 |
20160038654 | SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR VASCULOPATHIES - Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others. | 2016-02-11 |
20160038655 | Methods and Devices For Three-Dimensional Printing Or Additive Manufacturing Of Bioactive Medical Devices - A method for manufacturing a bioactive implant including the steps of (a) forming a mixture of an bioactive agent and a setting agent capable of transitioning from a flowable state to a rigid state; (b) converting the mixture into a flowable state; and (c) transitioning the mixture into a solid state in a shape of the implant. | 2016-02-11 |
20160038656 | INTRA-OPERATIVE BLOOD RECOVERY SYSTEM - A method for recovering blood from a blood-laden surgical sponge for autologous reinfusion, the method comprising the steps of: conveying negative pressure to a housing with the blood-laden surgical sponge; applying a predetermined force to draw the blood from the surgical sponge; and collecting the recovered blood. | 2016-02-11 |
20160038657 | MEDICAL DEVICES HAVING SURFACE MODIFIERS - Improved medical devices having anti-thrombogenic and anti-adherent surface modifiers for improved medical device performance and patient outcomes are provided. In certain embodiments, the medical devices are at least partially manufactured using an admixture of a base polymer and surface modifying fluoropolymer additives. In certain embodiments, the medical devices are vascular access devices, vascular access accessories, peripheral vascular devices, or components of these devices. | 2016-02-11 |
20160038658 | FLUID COLLECTOR UNIT OF WOUND DRAINAGE THERAPY SYSTEM AND COLLECTION CONTAINER THEREOF - A fluid collector unit of a wound drainage therapy system includes a multiple-pipe integration module and a collection bag. The multiple-pipe integration module includes first, second and third connection ports. The collection bag includes a negative-pressure buffer zone and two fluid collection zones that communicate with each other. The negative-pressure buffer zone is located between the two fluid collection zones and isolated from the two fluid collection zones. The two fluid collection zones are connected with the first connection port of the multiple-pipe integration module. The negative-pressure buffer zone is connected with the second and third connection ports of the multiple-pipe integration module, and the negative-pressure buffer zone has a fluid input port. | 2016-02-11 |
20160038659 | SYSTEMS AND METHODS WOUND DRAINAGE MANAGEMENT - Systems and methods for wound drain management. Certain embodiments include an infection indicator and/or a coupling device configured to such that a wound drainage container can rotate in relation to a mounting device. | 2016-02-11 |
20160038660 | SUCTION AND IRRIGATION INSTRUMENT AND METHOD OF USE - A surgical apparatus includes a first or suction tube, through which suction forces are applied through a tube-end opening along a longitudinal axis, and a second or irrigation tube, extending along Inc first tube, the second tube, through which irrigation fluid, typically liquids, travels, the second tube including apertures. through which irrigation fluid is expelled in an axial orientation different from the longitudinal axis. The suction and irrigation tubes form a circulation pathway for the introduced irrigation fluid and particulates, which are drawn into the suction tube by suction forces, tot properly clearing (flushing) the surgical site. | 2016-02-11 |
20160038661 | DENTAL SURGICAL SUCTION APPARATUS - A dental surgical suction apparatus combines the features and benefits of a surgical suction tip and a saliva ejector. The apparatus creates a more powerful suction force than provided by a saliva ejector by itself and can allow for better suctioning during oral surgery procedures and sedation, where keeping saliva and blood secretion from the throat can be critical, while also providing a device that is less traumatic to a patient's mouth. The apparatus can include a rigid tubular handle portion configured to releasably attach to a receiving port configured to receive a surgical suction tip on one end, a flexible tube portion connected to another end of the rigid tubular handle portion, and a soft tip portion connected to another end of the flexible tube portion. The soft tip portion includes a plurality of openings configured to minimize complete obstruction during suctioning. | 2016-02-11 |
20160038662 | DEVICE HAVING A FLOW CHANNEL - A device having a flow channel for a fluid has a nonreturn valve arranged in the flow channel, the nonreturn valve allowing the fluid to flow through the flow channel in a first direction and preventing it from flowing through the flow channel in a direction counter to the first direction. The device furthermore has a flow detector for detecting the flow of the fluid through the flow channel, wherein the flow detector detects a change in the nonreturn valve. This detected change serves as an indicator for the flow of the fluid. The device enables simplified flow detection, in that a nonreturn valve that is present is used as an indicator. | 2016-02-11 |
20160038663 | IMPLANTABLE PUMP WITH TAPERED DIFFUSER REGION - A blood pump, such as an axial flow pump, having a pump housing, the pump housing defining a flow path and having a tapered portion adjacent to an outlet, tapering toward the outlet, an outflow cannula connected to the outlet of the pump housing, and an impeller and diffuser, disposed in the pump housing, the diffuser having a tapered body corresponding to the tapered portion of the pump housing, the diffuser body having at least one vane extending therefrom, the vein tapering in the same direction as the diffuser body. The present invention also includes a method of manufacturing the blood pump and a method of implanting the blood pump. | 2016-02-11 |
20160038664 | MODULAR IMPLANTABLE MEDICAL PUMP - An implantable medical pump system can include a blood pump comprising a pump housing defining a passage therethrough and a rotor within the passage. The blood pump further includes one or more elements at least partially contained within the housing adapted to actuate the rotor to drive fluid though the passage. The pump housing includes at least one coupling feature. The system further includes an inflow cannula defining a lumen therethrough. The inflow cannula is adapted to be mechanically coupled to the at least one coupling feature. | 2016-02-11 |
20160038665 | EXTRACORPOREAL BLOOD TREATMENT FLUIDS INTERFACE - Extracorporeal blood treatment systems and methods to display status information for one or more fluids used in extracorporeal blood treatments. For example, a graphical user interface may include a fluids region depicting one or more fluid areas. Each fluid area may include pump and reservoir elements that depict flow rate information, reservoir volume information, and/or a notification related thereto. | 2016-02-11 |
20160038666 | HEMODIALYSIS SYSTEM HAVING A FLOW PATH WITH A CONTROLLED COMPLIANT VOLUME - Systems and methods for the performance of kidney replacement therapy having or using a dialyzer, control components, sorbent cartridge and fluid reservoirs configured to be of a weight and size suitable to be worn or carried by an individual requiring treatment are disclosed. The system for performing kidney replacement therapy has a controlled compliance dialysis circuit, where a control pump controls the bi-directional movement of fluid across a dialysis membrane. The dialysis circuit and an extracorporeal circuit for circulating blood are in fluid communication through the dialysis membrane. The flux of fluid moving between the extracorporeal circuit and the dialysis circuit is modified by the rate at which the control pump is operating such that a rate of ultrafiltration and convective clearance can be controlled. The system provides for the monitoring of an inlet and outlet conductivity of the sorbent cartridge to provide a facility to quantify or monitor the removal of urea by the sorbent cartridge. | 2016-02-11 |
20160038667 | SYSTEMS AND METHODS FOR DESTROYING CANCER CELLS IN BLOOD - An apparatus for destroying cancer cells in blood includes a vessel for accepting a flow of blood of a patient through the vessel, and a sound energy source coupled with the vessel for generating sound energy at a resonant sweep frequency that causes cancer cells, within the flow of blood in the vessel, to act as cavitation nuclei and implode without implosion of other cells not resonant with the resonant sweep frequency. A method for destroying cancer cells in blood includes circulating blood from a patient through a vessel coupled with a sound energy source and exposing the blood, when passing through the vessel, to sound energy at a resonant sweep frequency to make cancer cells therein act as cavitation nuclei and implode without implosion of other cells not resonant with the resonant sweep frequency. | 2016-02-11 |
20160038668 | Therapeutic Retrieval of Targets in Biological Fluids - Method and apparatus for removing high density particles from a biological fluid such as blood using aphaeresis. The particles are preferably sub-micron in size and denser than normally occurring components of the fluid and can be removed by a modified reverse-flow gradient density centrifuge without damaging the fluid. The particles can be provided to a patient in vivo or added to the fluid after it is removed from the patient. Some particles can carry and deliver oxygen and scavenge carbon dioxide. Other particles are conjugated to capture molecules for attaching to targets such as cancer cells, viruses, pathogens, toxins, or excess concentrations of a drug or element in the fluid. The targets are then removed from the fluid along with the particles by the aphaeresis instrument. | 2016-02-11 |
20160038669 | SYSTEM FOR DELIVERY OF FLUIDS SUCH AS AMMONIA NITROGEN 13 - This invention is directed to a delivery system that is able to deliver fluids, namely, ammonia nitrogen 13. Moreover, the delivery system is self-contained, manually portable, and capable of safely and effectively delivering ammonia nitrogen 13. Finally, the delivery system is capable of supplying up to 20 vials of fluid. | 2016-02-11 |
20160038670 | PUMP ASSEMBLY WITH A REMOVABLE COVER ASSEMBLY - An infusion pump assembly includes an enclosure assembly. A reservoir assembly is positioned at least partially within the enclosure assembly and is configured to contain an infusible fluid. A pump assembly is positioned at least partially within the enclosure assembly and is configured to effectuate the dispensing of the infusible fluid contained within the reservoir assembly. Processing logic is positioned at least partially within the enclosure assembly and is configured to control the pump assembly. A removable cover assembly is configured to releasably engage the enclosure assembly. A combination of the removable cover assembly and at least a portion of the enclosure assembly defines a power supply cavity configured to prevent a removable power supply assembly from being reverse-polarity electrically coupled to the processing logic. | 2016-02-11 |
20160038671 | INFUSION PUMP ASSEMBLY - A wearable infusion pump assembly includes a reservoir for receiving an infusible fluid, and an external infusion set configured to deliver the infusible fluid to a user. A fluid delivery system is configured to deliver the infusible fluid from the reservoir to the external infusion set. The fluid delivery system includes a volume sensor assembly, and a pump assembly for extracting a quantity of infusible fluid from the reservoir and providing the quantity of infusible fluid to the volume sensor assembly. The volume sensor assembly is configured to determine the volume of at least a portion of the quantity of fluid. The fluid delivery system further includes a first valve assembly configured to selectively isolate the pump assembly from the reservoir, and a second valve assembly configured to selectively isolate the volume sensor assembly from the external infusion set. | 2016-02-11 |
20160038672 | VENTED REFILL ARRANGEMENT AND ASSOCIATED TOOLS FOR IMPLANTABLE DRUG-DELIVERY DEVICES - Refill needles include a refill lumen for refilling a drug reservoir with a liquid and a venting channel for venting the device to be refilled. In various embodiments, the termini of the refill lumen and the venting channel are longitudinally displaced along the needle. | 2016-02-11 |
20160038673 | INSULIN TIME-ACTION MODEL - Described and shown herein is simple dynamic model for insulin time-action profiles. Various aspects are suitable for implementation in an embedded system such as an insulin pump, or a handheld device such as a pump remote control. Various aspects can be used as an off-line modeling tool running on a smartphone to assist patients in their treatment, or can be used as part of a closed-loop control algorithm for an artificial pancreas. | 2016-02-11 |
20160038674 | Infusion System Housing Medication Scanner And User Interface Device Displaying Delivery Data - The current subject matter describes a delivery of medication to a patient based on a scan of a medication container by a scanner implemented on an infusion system. The medication can include oral medications, injection medications, patches, and/or medication drops. The scanner can scan a machine-readable representation (for example, a barcode) on the medication container to obtain recommended delivery data. A user interface device of the infusion system can display the recommended delivery data on a graphical user interface. Based on the recommended delivery data and based on a patient diagnosis by a clinician, the clinician can determine actual delivery data. Based on the determined actual delivery data, the medication can be delivered to the patient via a non-infusion channel. Related apparatus, systems, techniques and articles are also described. | 2016-02-11 |
20160038675 | INFUSION PUMP ASSEMBLY AND METHOD - Some embodiments of an infusion pump assembly may be equipped with one or more components to facilitate wireless operation of an infusion pump via a user-operated mobile device. In some embodiments, the mobile device and/or the infusion pump may prompt the user to confirm acceptance of a wirelessly communicated command to prevent an operation by the infusion pump (e.g., a dispensation of medicine) that is not desired by the user. | 2016-02-11 |
20160038676 | Injection Device - The invention refers to a handheld injection device comprising a housing ( | 2016-02-11 |
20160038677 | Drug Delivery Device with Compact Power Unit - The present invention relates to a drug delivery device ( | 2016-02-11 |
20160038678 | Auto-Injector - The invention refers to an auto-injector for administering a dose of a liquid medicament, comprising:
| 2016-02-11 |
20160038679 | Injection Device - The present invention relates to an injection device comprising a medicament container ( | 2016-02-11 |
20160038680 | SUBCONJUNCTIVAL INJECTOR AND METHOD - An injection device and method are shown. Devices and methods include a forceps and a needle advancement mechanism to clamp a portion of tissue and control a depth of penetration of the needle between gripping ends of the forceps. An injection device and method are shown where selected components of the injection device such as a syringe and forceps are disposable, while the remaining portions of the injection device are reusable. Devices and methods are shown that utilize micro-needles to control a depth of penetration. | 2016-02-11 |
20160038681 | DEVICES AND METHODS FOR DELIVERING PARTICLES - Systems, devices, and methods for delivering therapeutic particles are disclosed. In one variation, a device for delivering particles includes a gas supply configured for supplying gas under pressure, a particle cassette comprising the particles, a cassette housing, and a cassette membrane. The cassette housing can comprise an Ethylene Vinyl Acetate (EVA) copolymer of 18% to 28% by weight of Vinyl Acetate (VA). The device can also include a safety interlock to prevent or minimize the risk that the device will be unintentionally activated. The device can also have a silencer. | 2016-02-11 |
20160038682 | TRACK-INDEXED SYRINGE - A finger grip arranged to be connected to a syringe barrel having a plunger and a plunger rod for driving said plunger. The finger grip includes a body having a lower side with finger supporting surfaces for supporting fingers of a user during handling and an engagement member being moveable between an inactive position where the engagement member is arranged not to engage with the plunger rod of the syringe barrel and an active position where the engagement member is arranged to engage with a grooved surface on the plunger rod of the syringe such that feedback is given to a user as the plunger is moved relative to the finger grip. An activation member for moving the engagement member from said inactive position to said active position is built-in into the finger grip. | 2016-02-11 |
20160038683 | Assembly for a Drug Delivery Device and Drug Delivery Device - An assembly for a drug delivery device ( | 2016-02-11 |
20160038684 | Medical Device Including An Air Evacuation System - Medical device assemblies capable of aspirating liquid into a syringe barrel or other medical devices while evacuating any air from the syringe are described. An exemplary medical device includes a syringe barrel, plunger rod and stopper assembly having an air permeable and liquid impermeable porous portion and structure for forming a vacuum within either the stopper or the plunger rod. Described is a medical device including a syringe barrel, plunger rod and stopper assembly having an air permeable and liquid impermeable porous portion and structure for forming a vacuum within chamber between the stopper and plunger rod wherein the plunger rod includes a sealing edge and is moveable relative to the stopper. Exemplary medical devices may include a vent for allowing air that permeates through the porous portion to escape to atmosphere. Methods for aspirating a syringe barrel with a liquid are also provided. | 2016-02-11 |
20160038685 | SYRINGE ASSEMBLER AND METHOD OF USE - A method for assembling a syringe includes supporting a syringe barrel having a stopper being movably disposed therein. A distal end of a plunger rod is inserted into the compartment of the syringe barrel. An initial digital image is taken of the stopper within the syringe barrel. The distal end of the plunger rod is coupled to the stopper located within the syringe barrel so that the plunger rod is secured to the stopper. A plurality of further digital images of the stopper within the syringe barrel are taken during or after coupling the distal end of the plunger rod to the stopper. Information determined from each of the further digital images is compared to information determined from the initial digital image using a computer processor to determine if the stopper in each of the further digital images has moved relative to the syringe barrel. | 2016-02-11 |
20160038686 | DISPENSING MECHANISM FOR A MEDICAL DEVICE - A dispensing mechanism for administering a dosage of a medicament includes dosage setting means ( | 2016-02-11 |
20160038687 | HANDHELD MEDICAL SUBSTANCE DISPENSING SYSTEM, APPARATUS AND METHODS - Various handheld medical dispensing configurations and methods including the following: Handheld medical dispensing system comprises a syringe, which has a plunger, releasably mounted to syringe actuation apparatus, the apparatus having an actuator configured such that it can move the plunger more than once to dispense a plurality of amounts of substance from the syringe. A method of dispensing fluid from a syringe comprises holding a medical substance delivery system including a syringe, which has a needle, and which is secured to syringe actuation apparatus configured to dispense predetermined amounts of the substance from the syringe, penetrating the needle at one patient site and using the apparatus to deliver a predetermined amount of the substance, and penetrating the needle at another patient site and using the apparatus to deliver a predetermined amount of the substance. | 2016-02-11 |
20160038688 | DUAL CHAMBER MIXING DEVICE FOR A SYRINGE - A mixing device and a retractable syringe comprising same are provided. The mixing device comprises concentric outer and inner barrels that form an outer chamber, the inner barrel having an inner chamber. A mixing plunger is slidably located in the outer chamber. A seal located in the outer chamber is capable of axial movement, in response to depression of the mixing plunger, from a first position in sealing engagement with one or more apertures in the inner barrel to a second position intermediate the apertures and vents in the outer barrel. This allows depression of the mixing plunger to force a first substance from the outer chamber through the apertures to mix with a second substance in the inner chamber. The mixed substance in the inner barrel is then delivered by the syringe with subsequent needle retraction. | 2016-02-11 |
20160038689 | BODY CONTOUR ADAPTABLE AUTOINJECTOR DEVICE - An injector for delivering a therapeutic product may include a base having a flexible surface that conforms to various body contours of a patient and defines one or more an injection chambers. The injector may have a height that is substantially less than its width, thereby defining a low profile, which provides a larger more stable base that can pinch or stretch the skin in a controlled manner. The larger base can also accommodate larger volumes via multiple injection chambers and/or large combined primary containers. | 2016-02-11 |
20160038690 | Vein Scanner with User Interface - An insulated bucket truck intercom facilitates safe/reliable bucket-to-cab and bucket-to-ground communications during truck operations, while in close proximity to high voltage power sources/lines. A truck-powered cab transceiver and battery-powered bucket transceiver are selectively interconnected by fiber optic cable to maintain high voltage electrical isolation of at least 10 KV/foot. A hands-free bucket transceiver liberates bucket workers from depressing a PTT button to communicate during repair operations. A PTT cab transceiver prevents stray sounds from distracting bucket workers. Bucket elevation through extension of the telescoping boom, with fiber optic cable secured thereto, is accommodated by a self-storing fiber optic reel assembly positioned at each section. Play in the cable and a spring-loaded pulley member accommodates boom articulation. A cab transceiver radio interface permits interference-free communication between the bucket transceiver and/or the cab transceiver, with a remote walkie-talkie up to 10 miles distant. A sensor warns of imminent truck tipping from boom overreaching. | 2016-02-11 |
20160038691 | INFUSION MEDIUM DELIVERY DEVICE AND METHOD WITH DRIVE DEVICE FOR DRIVING PLUNGER IN RESERVOIR - A delivery device includes first and second housing portions that selectively engage and disengage. A reservoir on one housing portion operatively engages a drive device and/or a needle inserting device on the other housing portion. Upon proper engagement of the housing portions, the reservoir operatively couples to the drive device and/or the needle inserting device. A first magnet on the first housing portion and a second magnet (or a magnetically-attractive material) on the second housing portion are positioned to magnetically interact with each other, upon operative engagement of the housing portions. A third magnet on the second housing portion may be opposed to the first magnet to help align the housing portions for connection. A magnet-responsive device may be on one or both housing portions to detect alignment and/or connection of the housing portions. | 2016-02-11 |
20160038692 | Internally controlled cell spray dispenser - Internally controlled cell spray dispenser comprises embodiments that are being used to generate spray by controlling a contact between solutions of different cellular composition and the incoming compressed air produced and triggered by an external source of compressed air. In order to obtain desired quality of spray the present apparatus uses the compressed air regulator, and elastic properties of the air channel valve to control both the circumference of the air channel, and the flow of air in to the frontal cone where the main contact between the two fluids is taking place. Reduced air channel is causing a reduction in flow of air and an increased air pressure in the air channel and in the frontal cone promoting discharge of thicker liquids and larger tissue grafts. Releasing the pressure exerted on the air channel valve is causing the air channel to elastically rebound allowing more air under less pressure to enter the frontal cone promoting a discharge of smaller particles suspended in thinner media. | 2016-02-11 |
20160038693 | DEVICE AND METHOD FOR DISCHARGING A REACTIVE LIQUID - A device and method for dispensing a liquid with a gas includes an instrument having a cannula and a low-pressure tip. The low-pressure tip includes a tip housing that at least partially defines a high pressure chamber. A distal wall of the tip housing includes an aperture in fluid communication with the high pressure chamber. The low-pressure tip also includes a tube and a gas flow channel. The tube fluidly communicates liquid at a relatively low pressure from the cannula through the first aperture. The gas flow channel fluidly communicates gas from the cannula at a relatively high pressure and to the high pressure chamber for discharge from the aperture. The tube and aperture are adapted to dispense the liquid and the gas in order to create a low pressure zone distal of the tube to dispense droplets of the liquid. | 2016-02-11 |
20160038694 | TROCAR SLEEVE - A trocar sleeve that isolates the surgical device or movement thereof to inhibit or prevent an established non-jet streaming condition from becoming a jet streaming condition and a method of inhibiting or preventing a jet streaming condition from occurring due to instrument obstruction. | 2016-02-11 |
20160038695 | MEDICINE BOX COUNTER - Disclosed is a medicine box counter, which comprise a case body, comprising a bottom seat, an upper cap movably combined with the case body, and a plurality of resilient elements disposed between the bottom seat and the upper cap. As such, the medicine and the bottom seat are directly combined so that when the user exerts a pressure upon the upper cap in the use course, the resilient elements may be indirectly extruded and thus the bottom seat triggers the count mechanism to count, and after the pressure on the upper cap is released, the upper cap automatically restores to its original position by means of the resilient elements, whereby achieving the efficacies of rapid assembly, convenient use, effective medicine-taken count and reduced manufacturing cost are provided. | 2016-02-11 |
20160038696 | DISPENSER - The present invention relates to dispensers, in particular to dispensers for dispensing a dose of a gaseous, gas borne or droplet substance from a substance source and dispensers comprising dosage counters. The present invention therefore provides a dispenser for dispensing a dose of a gaseous, gas borne or droplet substance from a substance source, the dispenser comprising: a body ( | 2016-02-11 |
20160038697 | MEASURING RESPIRATORY MECHANICS PARAMETERS OF VENTILATED PATIENTS - An airflow perturbation device for measuring respiratory resistance of a patient breathing with the use of a ventilator comprises a sealed housing having a first port and a second port each configured to couple to a ventilator hose, a perturbation mechanism to periodically alter air flow resistance between the first port and the second port, a pneumotachometer comprising a flow sensor to measure airflow between the first port and the second port, a pressure sensor to measure a difference in air pressure between the first port and the second port, and a computing system comprising at least one processor configured to receive data from the flow sensor and pressure sensor. The computing system determines an airflow resistance based on the received data. Embodiments of the present invention further include a method and computer program product for measuring respiratory resistance of a ventilated patient in substantially the same manners described above. | 2016-02-11 |
20160038698 | ADJUSTMENT OF TARGET VENTILATION IN A SERVOVENTILATOR - A servoventilator control slowly changes the target ventilation over a period of time, according to a preprogrammed schedule adapted to be set by the physician. Preferably, the target ventilation stays constant at an initial target ventilation for an initial hold time, and then increases at a constant rate until it reaches a final target ventilation, whereupon it stays constant thereafter. If the pressure support level is too high, possibly indicating glottic or upper airway closure, the rate of increase of target ventilation may be lowered or the final target ventilation not reached. | 2016-02-11 |
20160038699 | CUFF PRESSURE CONTROLLER DEVICE - A cuff pressure controller device ( | 2016-02-11 |
20160038700 | AIRWAY ADAPTERS AND SUCTION CATHETER SYSTEMS - Airway adapters and suction catheter systems, and methods of using the same, are described herein. An exemplary airway adapter assembly may comprise a connector body portion having a first end and a second end. The connector body portion may define an elongate cavity having an axial center between the first and the second end. The exemplary airway adapter assembly may also comprise a valve coupled to the second end of the connector body. The exemplary airway adapter assembly may also comprise a ventilation base member comprising a tubular portion coupled to the second end of the connector body portion and ventilator port. The ventilator port may comprises a conduit having a first conduit end and a second conduit end, and the first conduit end may be coupled to the tubular portion through an articulable connection. An exemplary closed suction catheter system may comprise a suction control valve assembly and a closed suction catheter sheath. | 2016-02-11 |
20160038701 | WASH PORT ASSEMBLIES FOR AIRWAY ADAPTERS - Wash port assemblies for airway adapters and methods are described. An example wash port valve assembly may include a multi-part housing defining a cavity and comprising a cap portion having a first hardness, and a base portion having a second hardness that has a hardness value greater than the first hardness. The cap portion may define an inlet port and the base portion may define an outlet port. The valve assembly may include an elastomeric valve disposed within the cavity and may be configured to be movably retained within the multi-part housing. The elastomeric valve may comprise a valve tip portion and a valve end portion distal of the valve tip portion. An example airway adapter assembly may include an adapter housing defining a cleaning chamber, and a wash port coupling assembly coupled to the wash port of the cleaning chamber. | 2016-02-11 |
20160038702 | VOICE ASSIST APPARATUS - The present invention provides a voice assist apparatus capable of vocalization in a near-natural voice by correctly flowing and blocking voice assist gas during expiration and inspiration, respectively, of a patient even when the pressure inside the operation tube relatively slightly increases and decreases. In the voice assist apparatus, the main body has a first chamber connected with a second end of the voice assist gas-inlet tube, a second chamber connected with a second end of the voice assist tube, a third chamber connected with a second end of the operation tube, a dividing wall dividing between the first chamber and the second chamber except an opening communicating the first chamber with the second chamber, and a membrane formed elastically deformably to open and close the opening and isolates the third chamber from the first chamber and the second chamber. | 2016-02-11 |
20160038703 | Method and Apparatus for Holding Oral Airway Devices - A device for securing an oral airway device in place with a patient's oral cavity. The device comprises a V-clamp which is slid along its upper edge in the direction of the oral airway device. After making contact with the oral airway device with the V-clamp, the user may choose to manipulate a screw disposed on the device and bring its corresponding distal end into physical contact with the opposing surface or side of the oral airway device, thereby creating a compressive force on the oral airway device. Alternatively, the device may comprise a V-clamp on a first portion which is disposed on a sliding track. The first portion may be manipulated with the addition of a screw in order to create a compressive force on the oral airway device. Alternatively, the device may comprise two rotating portions coupled together via a pivot point. | 2016-02-11 |
20160038704 | MEDICAL TUBE HOLDER - A medical tube holder, for securing a tube relative to a patient, comprises an elongate patient engaging portion for passing around at least a part of a neck and mouth region of a patient; a tube holding portion, connected to the patient engaging portion, for passing around at least a part of a medical tube; a tube-holding-portion securing arrangement for securing the tube holding portion around at least a part of the medical tube so that the medical tube can be securely positioned relative to the patient; and a patient-engaging-portion securing arrangement for securing the patient engaging portion around the patient's neck and mouth region to secure the medical tube holder to the patient. The patient-engaging-portion securing arrangement has a tightening arrangement to facilitate tightening of the patient engaging portion around the patient's neck and mouth region, and a locking arrangement that prevents loosening of the patient engaging portion while allowing further tightening. | 2016-02-11 |
20160038705 | BREATHING ASSISTANCE APPARATUS - In one embodiment, a nasal cannula is shaped to fit within a user's nares, where the nasal cannula includes at least one prong allowing high flow delivery of humidified gases and creates positive airway pressure in the patient's airway. The prongs have angled ends such that, in use, gases flowing through the prongs are directed to the user's nasal passages. The nasal cannula body is partially swiveling and preferably has a ball joint connector. In another embodiment the nasal cannula may have at least one flared end prong that preferably seals within a patient's nare. | 2016-02-11 |
20160038706 | BREATHING ASSISTANCE APPARATUS - Headgear for use with a respiratory mask is described. The headgear comprises a continuous and substantially curved elongate member extending in use below a user's nose and at least two headgear straps capable of attachment to the ends of the elongate member. A mask attachment on the elongate member is disposed to sit below or on one of said user's nose, mouth, upper lip and an inlet to the mask. The attachment is capable of receiving the mask. | 2016-02-11 |
20160038707 | PATIENT INTERFACE AND ASPECTS THEREOF - A patient interface has a single loop headstrap and a mask for covering at least the nostrils of the user. The single loop headstrap extends from the mask at either end. A short length of supple conduit is coupled to the mask by a swivel or ball joint to allow rotation of the conduit relative to the mask through different angles and orientations. | 2016-02-11 |